Suppr超能文献

1977年至2001年间,匈牙利西部某省炎症性肠病的发病率和患病率显著上升。

Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

作者信息

Lakatos Laszlo, Mester Gabor, Erdelyi Zsuzsanna, Balogh Mihaly, Szipocs Istvan, Kamaras Gyorgy, Lakatos Peter Laszlo

机构信息

1st Department of Medicine, Csolnoky F. Province Hospital, Veszprem, Hungary.

出版信息

World J Gastroenterol. 2004 Feb 1;10(3):404-9. doi: 10.3748/wjg.v10.i3.404.

Abstract

AIM

An investigation into inflammatory bowel disease and colorectal cancer in Veszprem Province was conducted from 1977 to 2001.

METHODS

Both hospital and outpatient records were collected and reviewed comprehensively. The majority of patients were followed up regularly.

RESULTS

The population of the province was decreased from 386,000 to 376,000 during the period. Five hundred sixty new cases of ulcerative colitis (UC), 212 of Crohn's disease (CD), and 40 of indeterminate colitis (IC) were diagnosed. The incidence rates increased from 1.66 to 11.01 cases per 100,000 persons for UC, from 0.41 to 4.68 for CD and from 0.26 to 0.74 for IC. The prevalence rate at the end of 2001 was 142.6 for UC and 52.9 cases per 100,000 persons for CD. The peak onset age in UC patients was between 30 and 40 years, in CD between 20 and 30 years. A family history of IBD was present in 3.4 % in UC and 9.9 % in CD patients. Smoking increased the risk for CD (OR=1.98) while it decreased the risk for UC (OR=0.25). Twelve colorectal carcinomas were observed in this cohort, the cumulative colorectal cancer risk after 10 years in UC was 2%, after 20 years 8.8%, after 30 years 13.3%.

CONCLUSION

The incidence and prevalence rates of IBD have increased steadily in Veszprem Province, now equivalent to that in Western European countries. Rapid increase in incidence rates supports a probable role for environmental factors. The rate of colorectal cancers in IBD is similar to that observed in Western countries.

摘要

目的

1977年至2001年对维斯普雷姆省的炎症性肠病和结直肠癌进行了调查。

方法

收集并全面审查了医院和门诊记录。大多数患者接受了定期随访。

结果

在此期间,该省人口从38.6万降至37.6万。诊断出560例新的溃疡性结肠炎(UC)病例、212例克罗恩病(CD)病例和40例不确定性结肠炎(IC)病例。UC的发病率从每10万人1.66例增至11.01例,CD从0.41例增至4.68例,IC从0.26例增至0.74例。2001年底UC的患病率为每10万人142.6例,CD为52.9例。UC患者的发病高峰年龄在30至40岁之间,CD在20至30岁之间。UC患者中有3.4%、CD患者中有9.9%有炎症性肠病家族史。吸烟增加了患CD的风险(比值比=1.98),而降低了患UC的风险(比值比=0.25)。在该队列中观察到12例结直肠癌,UC患者10年后的结直肠癌累积风险为2%,20年后为8.8%,30年后为13.3%。

结论

维斯普雷姆省炎症性肠病的发病率和患病率稳步上升,现已与西欧国家相当。发病率的快速上升支持环境因素可能起作用。炎症性肠病患者的结直肠癌发病率与西方国家观察到的相似。

相似文献

8
Inflammatory bowel disease in Iran: a review of 457 cases.伊朗的炎症性肠病:457例病例综述。
J Gastroenterol Hepatol. 2005 Nov;20(11):1691-5. doi: 10.1111/j.1440-1746.2005.03905.x.

引用本文的文献

7
The four epidemiological stages in the global evolution of inflammatory bowel disease.炎症性肠病全球演变的四个流行病学阶段。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):56-66. doi: 10.1038/s41575-020-00360-x. Epub 2020 Oct 8.
8
Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease.关注新视角:炎症性肠病的辅助治疗。
Can J Gastroenterol Hepatol. 2020 Aug 12;2020:7397523. doi: 10.1155/2020/7397523. eCollection 2020.

本文引用的文献

1
Inflammatory bowel disease in the Hubei Province of China.中国湖北省的炎症性肠病。
World J Gastroenterol. 1997 Jun 15;3(2):119-20. doi: 10.3748/wjg.v3.i2.119.
5
Hla-B genotype in Japanese patients with Crohn's disease.日本克罗恩病患者的Hla - B基因型
Dis Colon Rectum. 2003 Oct;46(10 Suppl):S10-4. doi: 10.1097/01.DCR.0000083386.69865.76.
8
Review article: colitis-associated cancer -- time for new strategies.
Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:6-9. doi: 10.1046/j.1365-2036.18.s2.5.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验